Search Results 111-120 of 15973 for GLP-1 agonist

  1. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after ... Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to ...

  2. Study Evaluating the Safety, Tolerability, and Effectiveness of EDP-305 in Subjects with Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... GLP-1 receptor agonists and thiazolidinediones) prior to Screening. NOTE: Sulfonylureas and insulin are only permitted if glycemia is self-monitored by the ...

  3. Integrated Assessment of Gastric Functions - Mayo Clinic

    Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may affect central processing of pain. Positive tissue transglutaminase antibodies ...

  4. Publications - Mark J. Spangehl, M.D. - Mayo Clinic

    GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty? J Arthroplasty. 2025 Mar ...

  5. Comparison of the Atmo Motility Gas Capsule System to the Reference Standard - Mayo Clinic

    Patients on long-acting glucagon-like peptide (GLP-1). Active implantable devices ... Unable to stop medications that may alter GI motility (GLP-1 agonists ...

  6. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

    Ongoing treatment with GLP-1 or amylin analogues or agonists. Any elective major surgery planned or anticipated at any time during the study. History of ...

  7. Medtronic study with Personalized Closed Loop - Mayo Clinic

    Subjects 7 years of age and older: Diagnosed at least 1 year prior to Visit 1; ... GLP-1 agonists), metformin, canagliflozin (Invokana or other SGLT2 ...

  8. Mucosal Impedance In Achalasia Patients After POEM - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness ... Receipt of glucagon-like peptide-1 agonists. Adults lacking the capacity to ...

  9. Wireless Patch System To Categorize Gastric Sensorimotor Disorders and Assess Response to Therapy - Mayo Clinic

    Are on chronic opioids or other medications known to affect gastric emptying (e.g., GLP-1 agonists, high dose tricyclic agents);; Have been recently ...

  10. Reducing Intestinal Permeability with Hemp Hull WFI in IBS-Diarrhea With Evidence of Bile Acid Diarrhea - Mayo Clinic

    Participation eligibility · Diabetes mellitus (type 1). · Diabetes mellitus type 2 if taking metformin or GLP-1 agonist treatment (exenatide, liraglutide, ...